USA flag logo/image

An Official Website of the United States Government

NUCLEIC ACID HYBRIDIZATION (NAH), AN EXTREMELY IMPORTANT MOLECULAR BIOLOGY…

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
4737
Program Year/Program:
1986 / SBIR
Agency Tracking Number:
4737
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Digene
Univ Of Maryland Bldg 334 College Park, MD 20742
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1986
Title: NUCLEIC ACID HYBRIDIZATION (NAH), AN EXTREMELY IMPORTANT MOLECULAR BIOLOGY RESEARCH TOOL, HAS THE POTENTIAL TO BE A MAJOR DIAGNOSTIC PROCEDURE.
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

NUCLEIC ACID HYBRIDIZATION (NAH), AN EXTREMELY IMPORTANT MOLECULAR BIOLOGY RESEARCH TOOL, HAS THE POTENTIAL TO BE A MAJOR DIAGNOSTIC PROCEDURE. HOWEVER, THE CURRENT TECHNIQUE REQUIRES THE USE OF EXPENSIVE, HAZARDOUS, AND TIME-CONSUMINGMETHODS BASED ON RADIOACTIVE MATERIALS. FURTHERMORE, NAH TESTS TYPICALLY RESULT IN EITHER NON-QUANTITATIVE OR ONLY SEMIQUANTITATIVE INFORMATION, A SERIOUS LIMITATION WHEN IT IS IMPORTANT TO KNOW IF AN ABNORMAL QUANTITY OF A SEQUENCE (E.G., ONCOGENES) IS PRESENT. A NEW NONISOTOPIC LABELING PROCEDURE WHICH TAKES LESS THAN 1 HOUR, REQUIRES LESS TOXIC AND LESS EXPENSIVE REAGENTS, APPEARS MORE RELIABLE, AND HAS A SENSITIVITY THAT IS HIGHER THAN PREVIOUS METHODS HAS BEEN IMPLEMENTED IN PRELIMINARY EXPERIMENTS. AN IMPROVED METHOD FOR QUANTIFYING RADIOACTIVE AND NONISOTOPIC HYBRIDIZATIONS BASED UPON COMPUTERIZED IMAGE PROCESSING HAS ALSO BEEN DEVELOPED. A PHASE I GRANT WILL PERMIT DIGENE TO: (1) TESTTHIS LABELING TECHNIQUE ON NUCLEIC ACIDS FROM TRANSFORMED CELLS TO DETERMINE THE FEASIBILITY OF USING THIS TECHNIQUE IN CLINICAL MEDICINE; AND (2) QUANTIFY THE EXTENT OF HYBRIDIZATIONS USING A PROTOTYPE IMAGE PROCESSING SYSTEM. IN PHASE II, THESE SYSTEMS WILL BE USED FOR THE ANALYSIS ANDQUANTITATION OF ONCOGENES, POTENTIALLY ONCOGENIC VIRUSES, AND CHEMOTHERAPY RESISTANCE IN A VARIETY OF CELL LINES AND CLINICAL SPECIMANS.

Principal Investigator:

Floyd taub
PRINCIPAL INVESTIGATOR
3014545906

Business Contact:

Small Business Information at Submission:

Digene
Building 34 University Of Maryland College Park, MD 20742

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No